General Pharmacology — MCQs

General Pharmacology Indian Medical PG Practice Questions and MCQs

Question 121: Which of the following is a potent microsomal enzyme inducer drug?

A. Captopril
B. Erythromycin
C. Rifampicin (Correct Answer)
D. Cimetidine

Explanation: **Explanation:** Microsomal enzyme induction refers to the process where a drug increases the synthesis and activity of cytochrome P450 (CYP450) enzymes in the liver. This leads to an accelerated metabolism of the inducer itself and other co-administered drugs, often resulting in decreased therapeutic efficacy. **Why Rifampicin is correct:** **Rifampicin** is one of the most potent known inducers of the CYP450 system (specifically CYP3A4, 2C9, and 2C19). It acts by binding to the Pregnane X Receptor (PXR), which triggers the transcription of enzyme-coding genes. Clinically, this is significant because it can lead to the failure of drugs like oral contraceptives, warfarin, and anti-retrovirals. **Analysis of Incorrect Options:** * **Captopril (Option A):** An ACE inhibitor used for hypertension. It does not significantly induce or inhibit hepatic microsomal enzymes. * **Erythromycin (Option B):** A macrolide antibiotic that is a well-known **enzyme inhibitor**. It binds to CYP3A4 and prevents the metabolism of other drugs (e.g., theophylline), potentially leading to toxicity. * **Cimetidine (Option D):** An H2-receptor antagonist that is a classic **enzyme inhibitor**. It inhibits multiple CYP isoforms, increasing the levels of drugs like phenytoin and warfarin. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Enzyme Inducers (GPRS Cell Phone):** **G**riseofulvin, **P**henytoin, **R**ifampicin, **S**moking, **C**arbamazepine, **P**henobarbitone. * **Mnemonic for Enzyme Inhibitors (VITAMINS K):** **V**alproate, **I**soniazid, **T**erfenadine, **A**miodarone, **M**acrolides (except Azithromycin), **I**ndinavir, **N**on-DHP CCBs (Verapamil/Diltiazem), **S**ulfonamides, **K**etoconazole/Cimetidine. * **Grapefruit juice** is a potent inhibitor of CYP3A4 in the intestinal wall.

Question 122: All the following drugs are inducers of cytochrome P450 enzymes except?

A. Ritonavir
B. Chloral hydrate
C. Isoniazid
D. Ketoconazole (Correct Answer)

Explanation: **Explanation:** The core concept tested here is the classification of drugs as **Cytochrome P450 (CYP450) Enzyme Inducers or Inhibitors**. Enzyme inducers increase the synthesis of CYP enzymes, leading to faster metabolism of co-administered drugs, whereas inhibitors decrease enzyme activity, potentially leading to drug toxicity. **Why Ketoconazole is the correct answer:** **Ketoconazole** is a potent **CYP450 inhibitor** (specifically CYP3A4). It binds to the heme iron of the cytochrome P450 enzyme, blocking the oxidation of substrates. In clinical practice, this leads to significant drug-drug interactions, increasing the plasma levels of drugs like warfarin, statins, and cyclosporine. **Analysis of other options:** * **Ritonavir:** While primarily known as a potent inhibitor, it exhibits a complex profile. In chronic administration, it acts as an **inducer** of certain isoforms (like CYP1A2) and glucuronosyltransferase. (Note: In many MCQ contexts, it is a "mixed" modulator, but less of a pure inhibitor than Ketoconazole). * **Chloral Hydrate:** This is a classic, though less commonly used, **enzyme inducer**. * **Isoniazid (INH):** This is a high-yield "trap" for students. While INH is a well-known *inhibitor* of CYP3A4 and CYP2C19, it is also documented as an **inducer of CYP2E1** (the enzyme that metabolizes ethanol and paracetamol). In the context of this specific question format, Ketoconazole is the most definitive and potent inhibitor. **NEET-PG High-Yield Pearls:** * **Mnemonic for Inducers (GPRS Cell Phone):** **G**riseofulvin, **P**henytoin, **R**ifampicin, **S**moking, **C**arbamazepine, **P**henobarbitone. * **Mnemonic for Inhibitors (VITAMIN K):** **V**alproate, **I**soniazid, **T**amoxifen, **A**miodarone, **M**acrolides (except Azithromycin), **I**ndinavir/Cimetidine, **N**avirs (Protease inhibitors), **K**etoconazole. * **Rifampicin** is the most potent known inducer. * **Grapefruit juice** is a specific inhibitor of intestinal CYP3A4.

Question 123: A partial agonist can antagonize the effects of a full agonist because it has:

A. High affinity but low intrinsic activity (Correct Answer)
B. Low affinity but high intrinsic activity
C. No affinity and low intrinsic activity
D. High affinity but no intrinsic activity

Explanation: ### Explanation **Concept Overview:** To understand this question, we must define two key parameters of drug-receptor interaction: 1. **Affinity:** The ability of a drug to bind to a receptor. 2. **Intrinsic Activity (Efficacy):** The ability of a drug to activate the receptor and produce a biological response once bound. **Why Option A is Correct:** A **Partial Agonist** has high affinity (it binds strongly to the receptor) but **low intrinsic activity** (it produces a sub-maximal response, usually between 0 and 1). When a partial agonist is added in the presence of a full agonist, it competes for the same receptor sites. Because it has high affinity, it displaces the full agonist; however, because it has lower efficacy, the overall maximal response of the system decreases. In this context, the partial agonist acts as a **competitive antagonist**, shifting the dose-response curve of the full agonist. **Analysis of Incorrect Options:** * **Option B:** Low affinity would mean the drug cannot effectively compete for the receptor, and high intrinsic activity is characteristic of a full agonist. * **Option C:** A drug with no affinity cannot bind to the receptor at all, thus it cannot exert any pharmacological effect or antagonism. * **Option D:** High affinity with **no intrinsic activity** (Intrinsic Activity = 0) defines a **Pure Antagonist**. While it antagonizes, the question specifically asks about a partial agonist. **NEET-PG High-Yield Pearls:** * **Intrinsic Activity Values:** Full Agonist = 1; Partial Agonist = 0 to 1; Antagonist = 0; Inverse Agonist = -1. * **Clinical Example:** **Pindolol** (a partial beta-blocker) acts as an antagonist when sympathetic tone is high (exercise) but acts as an agonist when tone is low (rest), preventing excessive bradycardia. * **Buprenorphine** is a partial $\mu$-opioid agonist used in opioid withdrawal because it displaces full agonists (heroin) but has a "ceiling effect" on respiratory depression.

Question 124: The duration of action of an intravenously administered drug depends on which of the following factors?

A. Protein binding
B. Clearance
C. Volume of distribution
D. All of the above (Correct Answer)

Explanation: **Explanation:** The duration of action of a drug is primarily determined by its **elimination half-life ($t_{1/2}$)**, which is the time required for the plasma concentration to reduce by 50%. The relationship is defined by the formula: $$t_{1/2} = \frac{0.693 \times V_d}{CL}$$ 1. **Volume of Distribution ($V_d$):** This represents the extent of drug distribution in the body. A high $V_d$ means the drug is sequestered in tissues, making it less available for elimination organs (liver/kidney), thereby **increasing** the duration of action. 2. **Clearance ($CL$):** This is the efficiency of the body to remove the drug. Higher clearance leads to a shorter half-life and a **shorter** duration of action. 3. **Protein Binding:** This is a crucial determinant of both $V_d$ and $CL$. Only the "free" (unbound) fraction of a drug is pharmacologically active and available for metabolism/excretion. High protein binding acts as a reservoir, slowing down the elimination process and **prolonging** the duration of action. **Why "All of the above" is correct:** Since $V_d$ and $CL$ are the primary physiological determinants of a drug's half-life, and protein binding directly influences both these parameters, all three factors collectively dictate how long a drug remains active in the body. **High-Yield Clinical Pearls for NEET-PG:** * **Redistribution:** For highly lipid-soluble drugs (e.g., **Thiopentone**), the duration of action is determined by redistribution from the brain to fat/muscles, rather than elimination half-life. * **Zero-order kinetics:** Drugs like Phenytoin, Alcohol, and Salicylates have a duration of action that increases disproportionately with dose because their clearance mechanisms saturate. * **Steady State:** It takes approximately **4 to 5 half-lives** to reach a steady-state concentration or to completely eliminate a drug from the body.

Question 125: Histamine acts on which type of receptors?

A. G protein coupled receptors (Correct Answer)
B. Ligand gated ion channels
C. Enzyme linked receptors
D. Intracellular receptors

Explanation: **Explanation:** Histamine is a biogenic amine that exerts its physiological effects by binding to four distinct receptor subtypes: **H1, H2, H3, and H4**. All four of these receptors belong to the **G-protein coupled receptor (GPCR)** superfamily [1], also known as metabotropic receptors. * **H1 receptors** are coupled to **Gq** proteins [3], leading to the activation of phospholipase C and an increase in intracellular calcium (mediating allergy and bronchoconstriction). * **H2 receptors** are coupled to **Gs** proteins [3], increasing cAMP levels (mediating gastric acid secretion). * **H3 and H4 receptors** are coupled to **Gi/o** proteins [3], which inhibit adenylyl cyclase. **Why other options are incorrect:** * **Ligand-gated ion channels:** These involve rapid flux of ions (e.g., Nicotinic ACh, GABA-A, NMDA receptors). Histamine does not directly open ion channels. * **Enzyme-linked receptors:** These possess intrinsic enzymatic activity, such as Tyrosine Kinase (e.g., Insulin, Growth Factor receptors). * **Intracellular receptors:** These are located in the cytoplasm or nucleus and bind lipid-soluble ligands like steroids, thyroxine, and Vitamin D. Histamine is water-soluble and cannot cross the cell membrane. **High-Yield Clinical Pearls for NEET-PG:** * **H1 Antagonists:** Used in allergic rhinitis and motion sickness (e.g., Cetirizine, Promethazine). * **H2 Antagonists:** Used in peptic ulcer disease to reduce acid (e.g., Ranitidine, Famotidine). * **Triple Response of Lewis:** Mediated by histamine, consisting of Red spot (capillary dilation), Flare (arteriolar dilation), and Wheal (exudation). * **H3 receptors** act primarily as presynaptic autoreceptors in the CNS [2], regulating neurotransmitter release.

Question 126: All of the following statements about mycophenolate mofetil are true except:

A. It is a prodrug
B. Gastrointestinal toxicity is common
C. It is used in transplant recipients where other drugs are not effective
D. It is highly nephrotoxic (Correct Answer)

Explanation: ### Explanation **Mycophenolate Mofetil (MMF)** is a potent immunosuppressant widely used in transplant medicine and autoimmune disorders. The correct answer is **D** because MMF is notably **not nephrotoxic**, which distinguishes it from other major immunosuppressants like Calcineurin Inhibitors (CNIs). #### Why Option D is the Correct Answer (The "Except"): Unlike Cyclosporine and Tacrolimus, which cause significant renal vasoconstriction and chronic interstitial fibrosis [1], MMF does not cause kidney damage. In fact, MMF is often used as a "renal-sparing" agent to allow for a reduction in the dose of nephrotoxic CNIs in transplant recipients. #### Analysis of Other Options: * **Option A (True):** MMF is a **prodrug** that is rapidly hydrolyzed in the liver to its active metabolite, **Mycophenolic Acid (MPA)**. * **Option B (True):** **Gastrointestinal (GI) toxicity** is the most common side effect [1]. Patients frequently experience nausea, vomiting, abdominal pain, and diarrhea. This is often the dose-limiting factor in clinical practice. * **Option C (True):** MMF is highly effective and is used as a first-line or rescue therapy in renal, hepatic, and cardiac transplants to prevent acute rejection, especially when other regimens fail or cause intolerable toxicity. #### NEET-PG High-Yield Pearls: * **Mechanism of Action:** It acts as a reversible inhibitor of **Inosine Monophosphate Dehydrogenase (IMPDH)**. This inhibits the *de novo* synthesis of guanosine nucleotides. * **Selectivity:** T and B lymphocytes are highly dependent on the *de novo* pathway (unlike other cells that use the salvage pathway), making MMF a **selective** lymphocyte inhibitor. * **Side Effects:** Apart from GI distress, it causes **myelosuppression** (neutropenia). * **Teratogenicity:** It is contraindicated in pregnancy (Category D) as it can cause "Mycophenolate Embryopathy" (ear and facial abnormalities).

Question 127: Which of the following is NOT an accepted use of Cyclosporine?

A. Organ transplant
B. Rheumatoid arthritis
C. Multiple myeloma (Correct Answer)
D. Recalcitrant psoriasis

Explanation: **Explanation:** **Cyclosporine** is a potent immunosuppressant that acts as a **calcineurin inhibitor**. It binds to cyclophilin, forming a complex that inhibits calcineurin, thereby preventing the dephosphorylation of NFAT (Nuclear Factor of Activated T-cells). This results in the inhibition of IL-2 production and T-cell proliferation. **Why Multiple Myeloma is the Correct Answer:** Multiple myeloma is a **plasma cell malignancy**. The mainstay of treatment involves proteasome inhibitors (Bortezomib), immunomodulators (Lenalidomide), steroids, and alkylating agents. Cyclosporine has no established role in treating plasma cell dyscrasias or hematological malignancies; in fact, long-term immunosuppression with cyclosporine can theoretically increase the risk of secondary lymphomas. **Analysis of Other Options:** * **Organ Transplant:** Cyclosporine revolutionized transplant medicine. It is a first-line agent for preventing graft-versus-host disease (GVHD) and organ rejection in kidney, liver, and heart transplants. * **Rheumatoid Arthritis (RA):** It is used as a Disease-Modifying Antirheumatic Drug (DMARD) in severe, active RA cases that do not respond adequately to methotrexate. * **Recalcitrant Psoriasis:** Due to its T-cell inhibitory action, it is highly effective for severe, plaque-type psoriasis that is resistant to topical therapies or phototherapy. **NEET-PG High-Yield Pearls:** * **Side Effects (Mnemonic: 5 H’s):** **H**irsutism, **H**yperplasia of gums, **H**ypertension, **H**yperlipidemia, and **H**epatotoxicity. * **Nephrotoxicity:** The most common and dose-limiting adverse effect (causes afferent arteriolar vasoconstriction). * **Monitoring:** Requires Therapeutic Drug Monitoring (TDM) due to a narrow therapeutic index. * **Drug Interactions:** Metabolized by CYP3A4; levels increase with Grapefruit juice and Ketoconazole.

Question 128: Nitroglycerine is effective when administered sublingually because it is:

A. Non-ionized and lipid-soluble (Correct Answer)
B. Ionized and lipid-soluble
C. Non-ionized and water-insoluble
D. Ionized and water-insoluble

Explanation: ### Explanation **1. Why Option A is Correct:** For a drug to be absorbed across biological membranes (like the sublingual mucosa) via passive diffusion, it must be **non-ionized** and **lipid-soluble**. [2] * **Non-ionized state:** Only the uncharged form of a drug can cross the lipid bilayer of cell membranes. * **Lipid solubility:** High lipid solubility (lipophilicity) allows the drug to dissolve into the membrane and enter the systemic circulation rapidly. [2] Nitroglycerine (GTN) possesses both these properties, allowing it to bypass the portal circulation (avoiding extensive first-pass metabolism) and provide rapid relief in angina pectoris. [1] **2. Why the Other Options are Incorrect:** * **Options B & D (Ionized):** Ionized (charged) molecules are water-soluble but lipid-insoluble. They cannot cross the lipid-rich cell membranes easily and require specific transport proteins or pores, making them poorly absorbed via the sublingual route. [2] * **Option C (Water-insoluble):** While lipid solubility is crucial for membrane crossing, a drug must have a minimal degree of aqueous solubility to dissolve in the salivary film before it can reach the mucosal surface. However, the primary barrier to absorption is the lipid membrane, making "non-ionized and lipid-soluble" the most accurate physiological requirement. **3. NEET-PG High-Yield Pearls:** * **First-Pass Metabolism:** GTN has a very high first-pass metabolism (>90%). Sublingual administration bypasses the liver, ensuring high bioavailability and a rapid onset of action (1–3 minutes). [1], [3] * **Storage:** GTN is volatile and adsorbed by plastic; it must be stored in tightly capped **dark glass bottles**. * **pH Dependency:** According to the **Henderson-Hasselbalch equation**, acidic drugs are better absorbed in acidic environments (stomach), and basic drugs in basic environments (intestine), because they remain in a non-ionized state. * **Other Sublingual Drugs:** Buprenorphine, Desmopressin, and Nifedipine (though the latter is no longer preferred due to reflex tachycardia).

Question 129: Cyclosporin is used as what type of drug?

A. Anticancer drug
B. Antibiotic
C. Antiarrythmic
D. Immunosuppressant (Correct Answer)

Explanation: **Explanation:** **Cyclosporine** is a potent **immunosuppressant** drug primarily used to prevent organ transplant rejection and treat autoimmune conditions. **Why the Correct Answer is Right:** Cyclosporine belongs to the class of **Calcineurin Inhibitors**. Its mechanism of action involves binding to an intracellular protein called **Cyclophilin**. This complex inhibits Calcineurin (a phosphatase), which is essential for the activation of the transcription factor **NFAT** (Nuclear Factor of Activated T-cells). Without NFAT, the transcription of **Interleukin-2 (IL-2)** is blocked, leading to the suppression of T-cell proliferation and the immune response. **Why the Other Options are Incorrect:** * **Anticancer drug:** While some immunosuppressants (like Methotrexate) are used in chemotherapy, Cyclosporine does not have direct cytotoxic or anti-proliferative effects on cancer cells. * **Antibiotic:** Although Cyclosporine was originally isolated from a fungus (*Tolypocladium inflatum*), it lacks significant antimicrobial activity. * **Antiarrhythmic:** Cyclosporine has no therapeutic effect on cardiac rhythm; in fact, it can cause hypertension as a side effect. **High-Yield Clinical Pearls for NEET-PG:** * **Indications:** Organ transplantation (Kidney, Liver, Heart), Graft-vs-Host disease, Psoriasis, and Rheumatoid Arthritis. * **Adverse Effects (The "H" Rule):** **H**ypertension, **H**irsutism, **H**yperplasia of gums (Gingival Hyperplasia), **H**yperlipidemia, and **H**yperkalemia. * **Nephrotoxicity:** It is the most common and dose-limiting side effect. * **Metabolism:** It is metabolized by **CYP3A4**; therefore, grapefruit juice (inhibitor) increases its toxicity, while Rifampicin (inducer) decreases its efficacy.

Question 130: What is the effect of competitive inhibition on Vmax and Km?

A. Km unchanged
B. Vmax increased, Km unchanged
C. Km increased, Vmax unchanged (Correct Answer)
D. Km and Vmax increased

Explanation: In competitive inhibition, the inhibitor structurally resembles the substrate and competes for the same **active site** on the enzyme. ### 1. Why the Correct Answer is Right * **Vmax Unchanged:** Because the inhibitor and substrate compete for the same site, the inhibition can be **overcome by increasing the substrate concentration**. At infinitely high substrate concentrations, the substrate outcompetes the inhibitor entirely, allowing the enzyme to reach its original maximum velocity ($V_{max}$). * **Km Increased:** $K_m$ (Michaelis constant) is the substrate concentration required to reach half of $V_{max}$. Since the inhibitor interferes with substrate binding, a higher concentration of substrate is needed to achieve the same rate of reaction. This reflects a **decreased affinity** of the enzyme for the substrate in the presence of the inhibitor. ### 2. Why Other Options are Wrong * **A & B (Km unchanged):** In competitive inhibition, $K_m$ must increase because the inhibitor "masks" the enzyme's affinity for the substrate. $V_{max}$ never increases in any form of inhibition. * **D (Vmax increased):** No inhibitor increases the maximum catalytic capacity of an enzyme. If $V_{max}$ were decreased and $K_m$ remained unchanged, it would describe **Non-competitive inhibition**. ### 3. NEET-PG High-Yield Pearls * **Lineweaver-Burk Plot:** On a double-reciprocal plot, competitive inhibition shows lines that **intersect on the Y-axis** (1/$V_{max}$ is constant). * **Clinical Examples:** * **Statins** (e.g., Atorvastatin) compete with HMG-CoA for HMG-CoA reductase. * **Methanol poisoning treatment:** Ethanol or Fomepizole competitively inhibits Alcohol Dehydrogenase. * **Sulfonamides** compete with PABA for Dihydropteroate synthase. * **Potency vs. Efficacy:** Competitive antagonists shift the dose-response curve to the right (**increase $EC_{50}$/decrease potency**) but do not change the maximal efficacy.

Practice by Chapter

Pharmacokinetics: Absorption and Distribution

Practice Questions

Pharmacokinetics: Metabolism and Excretion

Practice Questions

Pharmacodynamics and Receptor Theory

Practice Questions

Drug-Receptor Interactions and Dose-Response

Practice Questions

Pharmacogenetics and Personalized Medicine

Practice Questions

Adverse Drug Reactions and Toxicity

Practice Questions

Drug Interactions

Practice Questions

Drug Development and Regulation

Practice Questions

Pediatric and Geriatric Pharmacology

Practice Questions

Placental Transfer and Lactation

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free